AFC-HD AMS Life Science Co., Ltd.

TSE:2927 Stock Report

Market Cap: JP¥11.4b

AFC-HD AMS Life Science Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2927?
Owner TypeNumber of SharesOwnership Percentage
Institutions395,9062.82%
Employee Share Scheme405,7002.88%
Individual Insiders4,674,78733.2%
General Public8,587,41261.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 38.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
Hiromi Asayama
2,087,570JP¥1.7b0%no data
8.4%
Takehiko Asayama
1,181,930JP¥956.2m0%no data
2.88%
AFC-HD AMS Life Science Co.,Ltd, Client Stockholding Association
405,700JP¥328.2m0%no data
2.79%
Keiichiro Kinoshita
392,000JP¥317.1m0%no data
2.2%
Maiko Asayama
310,000JP¥250.8m0%no data
2.13%
Tadahiko Asayama
300,000JP¥242.7m0%no data
0.93%
JPMorgan Chase & Co, Brokerage and Securities Investments
130,800JP¥105.8m0%no data
0.92%
Keisuke Fujita
129,167JP¥104.5m0%no data
0.89%
The Shizuoka Bank Ltd., Asset Management Arm
124,900JP¥101.0m0%0.03%
0.85%
Dimensional Fund Advisors LP
119,208JP¥96.4m0%no data
0.75%
Chika Fukuchi
105,020JP¥85.0m0%no data
0.29%
Kazunori Takada
41,000JP¥33.2m0%no data
0.29%
Shigenori Fukuchi
41,000JP¥33.2m0%no data
0.23%
Naoya Unno
33,000JP¥26.7m0%no data
0.17%
Nobue Hamabe
23,800JP¥19.3m0%no data
0.13%
American Century Investment Management Inc
17,598JP¥14.2m-5.9%no data
0.094%
Yasuhiro Matsunaga
13,200JP¥10.7m0%no data
0.041%
Shigeo Minakata
5,700JP¥4.6m0%no data
0.036%
Shunji Sasahara
5,000JP¥4.0m0%no data
0.024%
Daiwa Asset Management Co., Ltd.
3,400JP¥2.8m0%no data
0.023%
Nobuyuki Maekawa
3,300JP¥2.7m0%no data
0.022%
Hiroshi Unno
3,100JP¥2.5m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 07:58
End of Day Share Price 2024/12/20 00:00
Earnings2024/08/31
Annual Earnings2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AFC-HD AMS Life Science Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution